The present invention relates to an antimicrobial composition derived from a natural substance. Since the composition effectively suppresses Filobasidium, an organism that has been newly identified as causing dandruff, the present invention can effectively prevent and/or treat seborrhoeic dermatitis and dandruff. Also, since the antimicrobial composition of the present invention includes a natural substance as an active ingredient, little consumer aversion will result. Also, it is expected that the antimicrobial composition of the present invention can be used for developing an antidandruff agent having a reduced content of materials which are typically used as antidandruff agents and the safety of which is questionable.

The present invention relates to an antimicrobial composition derived from a natural substance. Since the composition effectively suppresses Filobasidium, an organism that has been newly identified as causing dandruff, the present invention can effectively prevent and/or treat seborrhoeic dermatitis and dandruff. Also, since the antimicrobial composition of the present invention includes a natural substance as an active ingredient, little consumer aversion will result. Also, it is expected that the antimicrobial composition of the present invention can be used for developing an antidandruff agent having a reduced content of materials which are typically used as antidandruff agents and the safety of which is questionable.

The present invention relates to an antimicrobial composition derived from a natural substance. Since the composition effectively suppresses Filobasidium, an organism that has been newly identified as causing dandruff, the present invention can effectively prevent and/or treat seborrhoeic dermatitis and dandruff. Also, since the antimicrobial composition of the present invention includes a natural substance as an active ingredient, little consumer aversion will result. Also, it is expected that the antimicrobial composition of the present invention can be used for developing an antidandruff agent having a reduced content of materials which are typically used as antidandruff agents and the safety of which is questionable.

The present application relates to methods of preventing, treating or managing a respiratory disease and/or a viral infection (e.g., an influenza virus infection and COVID-19) using a pharmaceutical composition produced from one or more preparations of plant parts. Provided herein are the pharmaceutical compositions produced from the one or more preparations. Also provided herein are methods of producing the pharmaceutical composition from the one or more preparations.

The present application relates to methods of preventing, treating or managing a respiratory disease and/or a viral infection (e.g., an influenza virus infection and COVID-19) using a pharmaceutical composition produced from one or more preparations of plant parts. Provided herein are the pharmaceutical compositions produced from the one or more preparations. Also provided herein are methods of producing the pharmaceutical composition from the one or more preparations.

The present application relates to methods of preventing, treating or managing a respiratory disease and/or a viral infection (e.g., an influenza virus infection and COVID-19) using a pharmaceutical composition produced from one or more preparations of plant parts. Provided herein are the pharmaceutical compositions produced from the one or more preparations. Also provided herein are methods of producing the pharmaceutical composition from the one or more preparations.

Methods of maintaining general oral care as well as reducing inflammation, pain and bruising after oral surgery with a homeopathic recovery kit are disclosed.

Methods of maintaining general oral care as well as reducing inflammation, pain and bruising after oral surgery with a homeopathic recovery kit are disclosed.

Methods of maintaining general oral care as well as reducing inflammation, pain and bruising after oral surgery with a homeopathic recovery kit are disclosed.

The invention discloses an anti-viral therapeutic composition, which includes at least one anti-viral active ingredient originating from an aqueous Buchu extract or bio-active fraction thereof in a pharmaceutically acceptable form. The composition can be a pharmaceutical composition including a therapeutically effective amount of at least one or more anti-viral active ingredient and one or more pharmaceutically acceptable carriers or additives. The aqueous Buchu extract is obtained from the species Agasthoma betulina (round-leaf Buchu) and/or Agathosma crenulata (oval-leaf Buchu).